Columbia Financial, Inc. has disclosed a stock transaction involving its Chief Risk Officer, John Klimowich. This transaction is significant as it highlights the ongoing management activity within the company, which operates in the federally chartered savings institution sector.
Company Overview
Columbia Financial, Inc. is a federally chartered savings institution, classified under SIC 6035. The company trades under the ticker symbol CLBK on Nasdaq. It is categorized as an accelerated filer and has been active in the financial services sector, focusing on savings and loans.
Details of the Filing
According to the recent filing dated October 20, 2026, Klimowich reported a transaction that took place on October 16, 2026. He acquired 64.1631 shares of common stock at a price of $10.67 per share. Following this transaction, Klimowich holds a total of 20,852.5772 shares.
Impact on Stakeholders
This transaction may influence various stakeholders, including shareholders and employees, as it reflects the management's confidence in the company's future. The move is part of Columbia Financial's broader strategy to engage its executives in stock ownership, which can align their interests with those of shareholders.
What's Next
The filing does not say what happens next.
Executive Compensation Structure
John Klimowich serves as the Senior Executive Vice President and Chief Risk Officer of Columbia Financial, Inc. His recent stock acquisition is part of a broader executive compensation structure that includes various stock awards and options. The company has implemented a 2019 Equity Incentive Plan, which outlines the vesting criteria for stock awards, aligning executive compensation with company performance.
Ownership Breakdown
Post-transaction, Klimowich holds a total of 20,852.5772 shares directly. Additionally, he has significant indirect ownership through various plans: 145,056 shares held directly, 67,975 shares through a 401(k), and shares in other incentive plans, including ESOP and SERP. This diversified ownership structure indicates a strong commitment to the company's long-term success.
Future Stock Options
Klimowich also holds multiple stock options with varying exercise prices and expiration dates. For instance, he has options to purchase 414,117 shares at an exercise price of $7.10, which are fully vested and exercisable. Other options include shares priced at $7.25, $7.50, and $8.31, with expiration dates ranging from 2029 to 2036. This provides him with additional incentives tied to the company's stock performance over the coming years.
Conclusion
The filing does not include any information about Klimowich's future plans or other potential transactions he may be considering.